Xenetic Biosciences (XBIO) Bozor kapitallashuvining balans qiymatiga nisbati

xeneticbio.com (XBIO) korporativ emblemasi va logotipi

DNase ma'lumotlarini tahlil qilishni avtomatlashtirish va molekulalarni robotlashtirilgan skrining qilish Xenetic Biosciences uchun joriy rivojlanish vektorini belgilamoqda. GURU.Markets platformasidagi tarixiy bozor qiymatining buxgalteriya qiymatiga nisbatini solishtirib, biz aktivning barqarorligini ko'ramiz, bunda qiymat 0.79 darajasida qat'iy belgilangan. Bu litsenziyalash mumkin bo'lgan ishlanmalarni yaratish bo'yicha rahbariyat strategiyasining samaradorligini va laboratoriya sherikliklarining sinergiyasini tasdiqlaydi, bu esa Xenetic Biosciences kompaniyasining M&A jozibadorligini oshiradi.

Xenetic Biosciences, Inc. (XBIO) - Bozor kapitallashuvining balans qiymatiga nisbati 04.07.2022dan 31.10.2026gacha

Xenetic Biosciences (XBIO) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Narx grafigi xeneticbio.com|XBIO - Oʻrtacha prognoz narxi
- bozor kapitallashuvi tafsilotlari:
Bozor kapitallashuvi Xenetic Bio|XBIO - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Xenetic Biosciences|XBIO - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati xeneticbio.com|XBIO - Biznesning umumiy aktivlari
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Umumiy qarzning kapitalga nisbati Xenetic Biosciences|XBIO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati xeneticbio.com|XBIO - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Xenetic Bio|XBIO - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Xenetic Biosciences|Tezkor likvidlik koeffitsiyenti xeneticbio.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
XBIO - Sof daromad
Kompaniyaning har tomonlama tahlili:Xenetic Biosciences
Xenetic Biosciences yetakchi tovari

Ushbu ko'rsatkich biznesning bozor qiymatini uning sof aktivlariga nisbatan belgilaydi. P/B koeffitsiyenti o'zgarishlarini tahlil qilish orqali investor kitob qiymatiga nisbatan premium yoki diskontni aniqlashi mumkin. Ushbu metrika bozor kapitalizatsiyasini kapitalga bo'lish orqali hisoblanadi va spekulyativ nomutanosibliklarni ochib beradi. Xenetic Biosciences (XBIO) uchun ushbu ko'rsatkichning tebranishlari geosiyosiy to'siqlar tufayli kuchaygan. Sanktsiyalar va onkologik dori vositalari eksportining logistik inqirozi emitentning real aktivlari bahosiga bevosita ta'sir ko'rsatmoqda.

Xenetic Biosciences kimlar bilan raqobatlashadi

BeiGene Ltd (ONC) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti halozyme.com (HALO)|RVMD (Revolution Medicines, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma Group International (AAPG)|Bozor kapitallashuvining balans qiymatiga nisbati CGON|Bozor kapitallashuvining balans qiymatiga nisbati UroGen Pharma Corp (URGN)|Bozor qiymatining balans qiymatiga nisbati Bicara Therapeutics Inc. BCAX|PSNL: Kapitallashuvning balans qiymatiga nisbati|Erasca - Bozor kapitallashuvining balans qiymatiga nisbati|Delcath Systems Inc (DCTH) - Kapitallashuvning sof aktivlarga nisbati|YMAB: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Aura Corp (AURA)|Bozor qiymatining balans qiymatiga nisbati Candel Therapeutics Inc.|ARAY: Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati SLS (SELLAS Life Sciences)|ACTU (Actuate Therapeutics Inc.) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati CTOR (Citius Oncology, Inc)|HURA - Kapitallashuvning sof aktivlarga nisbati|TARA: Kapitallashuvning sof aktivlarga nisbati|FATE - Bozor kapitallashuvining balans qiymatiga nisbati|aadibio.com (WHWK) - Bozor qiymatining balans qiymatiga nisbati|TScan Therapeutics, Inc. - Balans qiymatiga nisbatan bozor qiymati|CSBR (Champions Oncology Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti XBiotech USA XBIT|Kapitallashuvning sof aktivlarga nisbati CVM (CEL-SCI Corporation)|ostherapies.com - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati RADX (Radiopharm Theranostics)|Artiva Biotherapeutics Inc. (ARTV) - Bozor qiymatining balans qiymatiga koeffitsiyenti|ANL - Bozor qiymatining balans qiymatiga nisbati|VERU (Veru Corporation) - Kapitallashuvning balans qiymatiga nisbati|TPST: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Xilio Therapeutics (XLO)|Kapitallashuvning sof aktivlarga nisbati RENB|MURA (Mural Bio) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati KAPA|Balans qiymatiga nisbatan bozor kapitallashuvi onkuretherapeutics.com|Bozor kapitallashuvining balans qiymatiga nisbati GDTC (CytoMed Therapeutics Limited)|CRIS - Kapitallashuvning sof aktivlarga nisbati|APLM: Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati THAR (Tharimmune Inc)|ADVB: Bozor kapitallashuvining balans qiymatiga nisbati|GNPX (Genprex Inc) - Bozor qiymatining balans qiymatiga nisbati|CLDI (Calidi Biotherapeutics Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|sunshinebiopharma.com (SBFM) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Salarius Pharmaceuticals, Inc. (SLRX)|PPBT - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati American Oncology Network, Inc. AONC|Balans qiymatiga nisbatan bozor kapitallashuvi BeiGene Ltd (BGNE)|Checkpoint Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|Elevation Oncology Inc. (ELEV) - Kapitallashuvning sof aktivlarga nisbati|ICAD: Bozor kapitallashuvining balans qiymatiga nisbati|IKNA - Balans qiymatiga nisbatan bozor kapitallashuvi|NTBL (Notable Labs Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Viracta VIRX|Bozor qiymatining balans qiymatiga nisbati MorphoSys AG (MOR)|nayabiosciences.com - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati AAPGV (Ascentage Pharma)